June 21, 2007 - Exforge, a single-tablet combination of two of the most prescribed high blood pressure medicines, has been granted final FDA approval for use in patients who suffer from high blood pressure.
Exforge is the first medicine of its kind to combine the active ingredients of an angiotensin receptor blocker, Diovan (valsartan) and a calcium channel blocker - Norvasc (amlodipine) - with the convenience of a single, once-daily tablet.
"High blood pressure continues to be a major public health issue in the US. Many patients will require multiple medications to achieve blood pressure control," said Bertram Pitt, M.D., FACC, and a professor of Medicine Emeritus at the University of Michigan School of Medicine Division of cardiology. "This new treatment offers great efficacy and improved convenience with a single tablet that will simplify treatment for patients."
For more information: www.exforge.com
July 16, 2026 
